Loading
Life sciences · Journal article
Discovery Medicine · October 23, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Aurora kinases, encompassing Aurora A, Aurora B, and Aurora C, function as essential regulators of mitosis by controlling checkpoints, centrosome dynamics, and cytokinesis; their dysregulation is a primary driver of uncontrolled cell proliferation, a hallmark of cancer. Although previous reviews have comprehensively summarized these roles, the present study offers a distinct advancement by quantifying the original contribution—a novel Aurora kinase–substrate interaction, a unique resistance mechanism, and a new therapeutic vulnerability, clearly setting this work apart from foundational studies. Our findings show that inhibition of this target selectively impairs tumor growth without affecting normal cells, thereby providing direct evidence that targeting this specific axis constitutes a viable and previously unrecognized strategy for cancer therapy. Together, these results not only elucidate the mechanistic functions of Aurora kinases in tumorigenesis but also provide actionable insights for the design of next-generation kinase.